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SEMEN QUALITY AND CHEMICAL OXIDATIVE STRESS; QUANTIFICATION
AND REMEDIATION
SALEEM A. BANI-HANI
ABSTRACT
The necessary multi-step process to prepare human semen for assisted
reproduction (AR) such as in vitro fertilization (IVF) is known to induce oxidative stress
in human spermatozoa and subsequent damage to the integrity of their cell components
and, thus, to their function. Literature reports have viewed this as a potential link with the
high frequency of birth defects among the IVF babies. In this work, we studied the effect
of incubation and centrifugation on human sperm quality using established AR protocols.
We found that in vitro incubation and centrifugation (20 min at 220g) of sperm generally
degrade sperm quality in terms of motility and DNA oxidation. The total antioxidant
capacity of the semen significantly decreased upon raising the centrifugation force from
220g to 400g. We then studied the efficacy of supplements such as L-carnitine (LC) on
remediating the oxidative stress. We found that supplementation with LC counteracts the
overall damage of quality brought by the multi-step method of sperm processing. We
determined the LC concentration range (0.1-1.0 mg/mL) with optimum oxidative stress
remediation and which enhances qualities such as motility. Among the various oxidative
stress species, we particularly focused on nitric oxide as a species with known dual
functional and cytotoxic properties. We have demonstrated a method to monitor its
dynamic concentrations in spermatozoa. The method enabled us to establish a link
between motility and nitric oxide levels in spermatozoa. The method also allowed us to
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establish that the LC-induced enhancement of human sperm motility is also accompanied
with a simultaneous increase in NO production.
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CHAPTER I

INTRODCUTION AND OVERVIEW

1.1 Assisted reproductive technologies

Assisted reproductive technologies (ART) are the artificial techniques used to
facilitate the pregnancy for couples who are trying to conceive without success. The most
common ones are In vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI) and
intrauterine insemination (IUI) [1; 2].

In IVF, the fertilization process, i.e. sperm and egg fusion, occurs outside the
female’s body in the Petri dish. The ultimate goal of this procedure is to increase the
chance of fertilization that is not achieved through the normal intercourse. In IVF, the
oocyte production is first induced using hormonal therapy. After ovulation, the eggs are
retrieved from the female’s ovary; in the meantime, sperm, fresh or cryopreserved, from
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the male are prepared and added to the female’s oocytes. The fertilized egg (gamete) is
then incubated at 37ºC in the dark in highly sterilized conditions until the embryo is
formed. After that, the embryo is transferred and placed in the center of female’s uterus
in order to achieve the pregnancy. In fact, several embryos are usually prepared and
placed into the uterus so as to increase the success rate of the process.

The main primary steps of ovarian induction, oocyte retrieval technique, sperm
preparations and embryo culture methods in IVF cycles are similar to those in ICSI
cycles. Unlike IVF, in ICSI, the spermatozoa is selected based on certain criteria;
spermatozoa of good motility and morphology is selected and injected artificially by the
embryologist using a mico-needle inside the oocyte [3; 4] (figure 1-1). ICSI technique is
mainly used to solve problems of severe male factor infertility as well as other problems
that lead to failure of natural fertilization [3; 5].
In IUI, highly-motile washed sperm are injected into the female’s uterus using a
special plastic catheter [6]. The rationale of this method is to increase the number of
highly-motile sperm at the site of fertilization, and hence increasing the probability of
fertilization. IUI is used in cases where the sperm are unable, or barely able, to reach the
oocyte in the female’s body spontaneously. Such conditions are sexual dysfunction,
asthenospermia (low sperm motility), and antagonistic cervical conditions such as
increased cervical mucus thickness [6; 7; 8; 9].

2

Figure 1-1: ICSI procedure. (A) the selected spermatozoa is immobilized and aspirated
into a microinjection pipette;(B) the oocyte is secured using a holding pipette and a
microinjection pipette; (C) the trapped spermatozoa is injected gently into the oocyte.
(Adapted from M.C.Schiewe I, 1996).
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1.2 Human semen processing for ART

Whether the sperm is fresh or cryopreserved, semen processing is routinely
performed in all ART. Contemporary processing techniques of sperm preparation for
ART require prolonged incubation as well as repeated centrifugation of human semen to
separate sperm from the seminal plasma at speeds of 200-400g for 10 to 20 minutes. The
processing of sperm should be gentle to allow the recovery of highly motile spermatozoa
that are morphologically and functionally normal. Nevertheless, reports show that sperm
centrifugation may generate low sperm quality, likely, by affecting the DNA integrity of
sperm [10; 11]. New findings suggest that some birth defects occur more often among
infants conceived with ART [12].

1.3 Reactive oxygen species and oxidative stress

Free radicals are highly reactive molecules or atoms that contain an unpaired
electron. Among free radicals in biological systems, reactive oxygen species (ROS) are
the most important due to their high reactivity in the body (figure 1-2). They are
associated with the onset of a variety of diseases including cancer, arteriosclerosis,
cardiovascular disease, infertility, and a host of inflammatory diseases [13]. The most
important ROS in the human body are superoxide radical (O2–·), hydroxyl radical (·OH),
Nitric oxide (NO), and the non-radical derivative hydrogen peroxide (H2O2) [14].
Endogenous entities such as mitochondria [15], peroxisomes, lipoxygenases, NADPH
oxidase and cytochrome P450 as well as exogenous factors such as ultraviolet light,
ionizing radiation, chemotherapeutics inflammatory cytokines, and environmental toxins
are considered as to be among major factors that generate ROS in living cells [16].
4

Figure 1-2: Lewis structure of dioxygen and some reactive oxygen species (ROS).
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In live cells, the disturbance in the balance between oxidants and antioxidants in
the favor of the former is termed as oxidative stress. Increased levels of free radicals such
as O2–·, NO and ·OH are capable of damaging DNA as well as the proteins and lipids,
and ultimately leads to cell injury or cell death (Figure 1-3) [17; 18]. The mechanisms of
the products formed by oxidative stress vary depending on the nature of free radical and
its molecular target [18]. Some of oxidative products could be a rigid sign of oxidative
stress and can be used as markers to assess the extent of the oxidative damage. For
example, 8-oxo-guanine (8-oxodeoxyguanosine) serves as a sensitive marker to estimate
the level of DNA damage caused by hydroxyl radicalS [19; 20].

1.4 Antioxidants role in human body
Antioxidants are substances capable of counteracting the free radical oxidative
damage in body tissues [17]. They could be dietary, such as -tocopherol (vitamin E) and
ascorbic acid (vitamin C), or synthesized in the body like glutathione [21]. Antioxidants
have attracted a great deal of attention for the defense they provide against oxidative
stress [17]. Several studies showed that supplementation of dietary antioxidants such as
vitamin E and β-carotene is associated with decreasing the risk of many diseases, such as
heart diseases [22], cancer [23], Alzheimer’s disease, Parkinson’s disease, and
amyotrophic lateral sclerosis [24; 25; 26].

6

1.5 Oxidative stress, antioxidants and human sperm quality in assisted reproduction

Oxidative stress in human spermatozoa may be due to the lack of molecular defense
mechanisms and increased sources of ROS [27]. Various studies have reported the role of
oxidative stress in male infertility pathogenesis [28; 29]. Male infertility problems such
as asthenozospermia and necrozoospermia may due to oxidative stress [27]. Similar to
the effect of oxidative stress in other types of cell types, both sperm DNA and sperm
membrane are affected negatively by oxidative stress (Figure 1-3), which consequently
decreases the change of reproductive outcomes [27].

Sperm preparation for assisted reproductive technologies includes various routine
steps such as incubation, cryopreservation and centrifugation. This induces oxidative
stress and subsequently affects negatively the quality of sperm. The use of antioxidants to
improve human sperm quality during processing for ART have been used extensively in
the last 2 decades. Although there is a great evidence supporting the use of antioxidants
to improve sperm quality in assisted reproduction [30; 31; 32; 33], optimal concentrations
and the correct combination of the antioxidants should be cautiously standardized. In
chapter III we will report on the efficacy of L-carnitine, a potent antioxidant, in
improving sperm quality during centrifugation and prolonged incubation in vitro for use
in ART protocols.

7

Figure 1-3: semen processing for ART such as IVF induces ROS against sperm.
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1.6 Flow cytometry: an overview

In our experimental work, we intensively used flow cytometry to explore the
effect of various factors affecting human spermatozoa in assisted reproduction. In
addition, we standardized a method to detect the intracellular nitric oxide in human
spermatozoa using flow cytometry. Therefore, there is a need to provide an overview of
the main principles and fundamentals of this technique.
Flow cytometry is a technique for the analysis of various parameters of individual
cells. It is used in a wide range of applications to measure different cell characteristics
such as size, fluorescence, shape, viability, intracellular pH, intracellular redox state, and
others. Besides, a variety of cell components can be determined using flow cytometry
such as DNA, RNA, protein, Lipid, antigens, surface receptors, calcium and others. The
flow cytometer achieves this analysis via passing a representative population of cells
from the sample through a laser beam and capturing the emerged light from each
individual cell as it passes through [34].
The main components of the flow cytometer are: (a) the fluidics (hydrodynamic
focusing system). This system allows the chosen cell population to pass the laser beam
one at a time (Figure 1-4). The intersection point between the laser beam and the cell is
termed as interrogation point. (b) The laser, which represent the light source in the flow
cytometer. (c) The optics, their main function is to gather the light from the cells after
crossing the laser beam. (d) The detectors; they receive the accumulated light from the
optics. (e) The computer system and other electronics, which convert the detector’s
signals into digital data and analyzes the data [34; 35; 36].

9

At interrogation point, when the cell crosses the laser beam, two types of light
scatter are formed: (a) forward scatter (FSC), which is the light, scattered in the forward
direction, and (b) side scatter (SSC), which is the light scattered on the sides (Figure 1-4).
In general, the forward scatter provides information about the size of the cell, whereas the
side scatter provides information about characteristics within the cell such as granularity
inside the cytoplasm, shape of nucleus, and membrane irregularity [37; 38; 39].

10

Figure 1-4: a representative scheme of flow cytometer system (see the text for details).
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FSC is proportional to the size of cells that are passing the laser [38]. The bigger
the cell size, the higher the FSC intensity. The detector converts the forward scattered
light into a voltage pulse. Hence, the size of cell is finally proportional to the magnitude
of the voltage pulse. The plot of cell count versus FSC is called forward scatter histogram
(FSCH) (Figure 1-5). In this histogram, the larger cells appear on the right.
SSC is the light scattered at higher angles compared to the FSC. The main
determinants of the angles of the scattered light are the structural complexity of the cell,
as we have mentioned above. A separate detector in the flow cytometer, other than one
used for FSC, is used to gather the side scattered light; it is usually placed 90° from the
laser beam path. The plot of cell count versus SCC is also a one-dimensional histogram
named side scatter histogram (SSCH) (Figure 1-6). It is similar to the FSCH, but it
provides information about the cells characteristics under investigation.

12

Figure 1-5: Flow cytometry forward scatter-histogram. Cells are sorted according to their
sizes

Figure 1-6: Flow cytometry side scatter-histogram. Cells are sorted according to their
complexity fluorescence.

Figure 1-7: Flow cytometry fluorescence-histogram.
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Fluorescence is another phenomenon used as handle to quantify a given property
within cells. At the fundamental levels, it is a term used to describe light emission,
mainly visible, from an excited fluorophore. The emission occurs when the fluorophore
returns to its ground state from an excited state. Figure 1-8 is the Jablonski diagram
(energy state diagram) of a fluorophore excitation and emission. The emitted light from a
fluorophore occurs at a higher wavelength. For example, the fluorophore fluorescein
isothiocyanate (FITC) that we used in this work to detect DNA oxidation can be excited
with the blue light at 494 nm; while it emits the green light at 518 nm.
Fluorescence emitted from cells labeled with a fluorophore travels in the same
path in the flow cytometer as the side scatter light. This path contains a number of light
filters so as to deliver each range of wavelengths to the proper detector. Same as data
collection in the cases of FSC and SSC, the light directed to the detector is translated into
a voltage pulse. The more the light emitted from the cell, the higher the voltage pulse
translated. The plot of intensity of fluorescence versus cell count is termed as flow
cytometry fluorescence-histogram, which provides information about cell fluorescence
that is increasing in the right direction (Figure 1-7).

14

Figure 1-8: Jablonski diagram (Energy state diagram) - fluorophore excitation and
emission. The fluorophore emission usually occurs at a lower wavelength; for example,
the fluorophore Fluorescein isothiocyanate (FITC) can be excited at 494 nm, while it
emits the light at 518 nm.

15

Forward scatter histogram is not necessarily showing the complexity of the cells.
In other words, the peak population that appears in the FSCH could be a representative of
multiple population. This problem can be resolved by looking at the data in the second
dimension using a two-dimensional scatter plot or dot plot (Figure 1-9). In this plot (SSC
versus FSC), we can look at both cellular parameters together: cell size and cell
complexity.

Another important problem in flow cytometry is to analyze only the cells of
interest. In many cases, cell fragments such as, small immature cells and debris, and
sometimes bigger cells that are not of interest interfere with the measurement. This
problem can be solved by establishing a threshold, or discriminator before start analyzing
the cells. This will exclude interferences for compounds that are not of interest.

16

Figure 1-9: flow cytometry Scatter or dot plot. Cells are analyzed for both complexity
and size.
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CHAPTER II

SEMEN QUALITY DURING PREPARATION FOR ASSITED REPRODUCTIVE
TECHNOLIGIES

2.1 Introduction

Sperm centrifugation, required for sperm washing, is a routine technique during
sperm processing for assisted reproduction technologies (ART). Reports from our
laboratory showed a significant increase in reactive oxygen species (ROS) during sperm
centrifugation. Studies have shown a decrease in fertilizing capacity of human
spermatozoa, and an increase in the birth defects among the ART babies compared to the
normal babies. Here, we examine the effect of centrifugation on total antioxidant capacity
(TAC) of human semen on one hand, and on DNA oxidation, motility, and viability of
sperm, on the other. We measured sperm motility, viability TAC and sperm DNA
oxidative damage after centrifugation of semen samples for 20 min at 220g. DNA
oxidative damage in sperm was measured using both electrochemical and flow cytometry
methods. Centrifugation significantly decreased sperm motility. The total antioxidant

23

capacity of the semen significantly decreased upon raising the centrifugation force from
220g to 400g. Concomitantly, the baseline of DNA oxidative damage in sperm increased
after centrifugation. Together, sperm centrifugation during processing for ART increases
oxidative stress in sperm, which negatively affects their quality. This could be one factor
behind the negative reproductive outcomes.

2.2 Research methods and experimental design

In this chapter we aimed to examine the effect of centrifugation on sperm quality
according to the assisted reproduction protocols. We used DNA oxidation, motility and
viability of sperm, as well as total antioxidant capacity (TAC) of semen as measurement
criteria to study this effect. The oxidative DNA damage in sperm was evaluated using
both electrochemical and flow cytometry techniques. We also adapted an assay based on
cupric reducing antioxidant capacity (CUPRAC) to measure the TAC in human semen
[1].

2.2.1 Sample collection

The present study was approved by the institutional review board of Cleveland Clinic
Hospital. Forty normospermic men were chosen and analyzed on the basis of normal
semen analysis according to the World Health Organization (WHO, 1999) guidelines [2].
The effect of centrifugation on TAC of semen as well as DNA oxidation, motility and
viability of sperm were examined. Samples were centrifuged at 1600 rpm (220g) for 20
minutes similar to sperm preparation protocols used in ART. Samples were collected by
masturbation after a minimum of 48 to 72 hours of sexual abstinence. Following
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liquefaction at 37 ºC for 20 minutes, semen specimens were evaluated for volume, sperm
concentration, total cell count, motility, and morphology.

2.2.2 Effect of centrifugation on sperm motility and viability
Two equal aliquots (5 X 106 sperm) were prepared from each of the sixteen
normospermic semen samples, and mixed with human tubal fluid (HTF; 1:1 vol. / vol.).
The first aliquot was centrifuged at 1600 rpm at 25 ºC; while the second aliquot (control)
was just incubated at the same temperature. Sperm motility and viability was measured
after 20 min. A total amount of 5µL of the sample was used for evaluation of
concentration and motility using a micro-cell slide chamber (Figure 2-1) (Conception
Technologies, San Diego, CA).
Sperm viability was measured by the Eosin-Nigrosin staining method (Figure 22). To one drop of liquefied semen placed on a Boerner slide, two drops of 1% aqueous
Eosin was added and mixed with a wooden stirrer for 15 seconds. Then, three drops of
10% aqueous Nigrosin were added and mixed well. Thin smear was made by pipetting
10µL onto a slide and allowed to air dry. Slides were mounted with a coverslip using
Accu-mount media. Measurements were performed on two hundred sperm counted on
each slide in duplicate sets using an X100 objective. Percentage of viable (unstained)
sperm and non-viable (stained) were calculated.
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Figure 2-1: Sperm motility assessment. 5µL of semen sample is used to assess motility
using a disposable micro-cell slide chamber (an example is shown in the figure).
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Figure 2-2: Sperm viability measurement using the Eosin-Nigrosin test. Stained sperm is
considered viable, while unstained one (white) is considered non-viable.
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2.2.3 Effect of centrifugation on total antioxidant capacity

Semen samples (n=10) from healthy donors, were divided into two aliquots; each
contained 0.5 mL of semen. We centrifuged the first aliquot at 220g for 20 min at 25 ºC,
while the second aliquot (control) was incubated for 20 min at the same temperature.
Semen samples (n=10), in another experimental set, were subjected to the same treatment
as described above, but centrifuged at a higher centrifugal force (400g).

We adapted the cupric reducing antioxidant capacity (CUPRAC) method to
measure the total antioxidant capacity in semen [1]. Briefly, 1 mL of working solution
(CuCl2 solution; 0.02 M), neocuproine alcoholic solution (0.0075 M) and 1-mL
ammonium acetate (NH4Ac) buffer solution (1:1:1 vol./vol./vol.) was mixed in a
centrifugation tube with 12.5 μL of seminal plasma. All reaction tubes were centrifuged 3
min at 4000 rpm, and the entire supernatant was collected for use in absorbance
measurements. The absorbance of the colored complex formed was measured against the
reagent blank at 450 nm after 30 min incubation at room temperature (Figure 2-3) [3].
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Figure 2-3: Cupric ion reducing antioxidant capacity (CUPRAC) principle. The colored
complex (Neocuproine-Cu+1) is formed after reducing cupric ion by semen antioxidants.
The intensity of the color is proportional to the total antioxidant activity in semen.
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2.2.4 Measurement of DNA oxidation by Flow cytometry
Semen samples (n=5) from healthy donors were divided into 2 aliquots (5 X 106
sperm) and centrifuged at 1600 rpm for 20 min. at 25ºC. Controls were incubated for 20
min. at 25ºC.

Oxidative damage to DNA was evaluated using the flow cytometric

OxiDNA assay kit (Calbiochem, San Diego). The assay is based on fluorescent protein
that binds to oxidized moieties on DNA (Figure 2-4). Briefly, both treated sperm samples
and controls were washed in phosphate saline buffer, resuspended in 1%
paraformaldehyde at a concentration of 2-4 x 106 cell/ mL, and placed on ice for 15 to 30
minutes. Sperm were again washed and resuspended in 70% ice-cold ethanol by
centrifugation at 300g for 5 minutes as per kit instructions. The ethanol supernatant was
removed, and the sperm pellets were washed twice in the wash buffer and resuspended in
100 µL of the staining solution for 1 hour at room temperature in dark. The staining
solution contained FITC-labeled protein conjugate in distilled water. All cells were
further washed using rinse buffer, resuspended in 250 µL and incubated for 30 minutes in
the dark on ice for flow cytometry measurements.

Data acquisition was performed within 30 min on a flow cytometer equipped with
a 515-nm argon laser as a light source (FACScan; Becton Dickinson, San Jose, CA).
10,000 cells were examined for each assay at a flow rate of 100 cells/ second. The FITC
fluorescence was measured and data analysis was performed using FlowJo v4.4.4
software (Tree Star Inc., Ashland, OR).
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Figure 2-4: Experimental design of assessment of DNA oxidation using flow cytometry.
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2.2.5 Measurement of DNA oxidation by Electrochemistry

Semen samples (n=5) from healthy donors were divided into 2 aliquots (sample
and control). Each aliquot (5 X 106 Sperm) was exposed to 20 min centrifugation at 1600
rpm under 25 ºC. Controls of the same sperm concentration were incubated for 20 min at
25ºC without centrifugation.

2.2.5.1 Sperm DNA Extraction

Cell lysis buffer (0.5 mL) and 60 µL of protinase K were added to both samples
and controls and incubated overnight at 55 ºC. A 0.5 mL aliquot of chloroform: phenol
mixture (1:1 vol./ vol.) was added and centrifuged for 5 min at 6000 rpm. The
supernatant (aqueous layer) was collected, and 0.5 mL of chloroform was added,
vortexed and centrifuged. The top layer was collected and mixed with 0.5 mL isopropyl
alcohol to salt-out the white DNA pellet. The precipitated DNA was collected by
centrifugation and the supernatant was gently decanted. Finally, the DNA was dissolved
in 200 µL Tris-EDTA buffer and kept at 4ºC for future use.

2.2.5.2 DNA film preparation
DNA films were prepared by layer-by-layer electrostatic assembly method [4].
The method is simply based on adsorbing thin layers from two polyelectrolytes with
opposite charge (in this case: poly (diallyldimethylammonium chloride) (PDDA) and the
DNA sample under investigation). Disks of ordinary basal plane pyrolitic graphite (PG)
were abraded with 400 grit silicon carbide (SiC) paper and sonicated in water for 1 min,
then rinsed with water and dried. The graphitic surfaces of these electrodes are then
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oxidized in 2.5%K2Cr2O7 by scanning the potential once from 1.5V to 1.75V
versus Ag/AgCl to form negative carboxylate groups on the surface [5]. Layers were
formed by placing a drop of each adsorbate solution on the PG electrode for 15-20 min.
The electrode was then rinsed with water to remove weakly adsorbed DNA and dried
between adsorption steps. The times for steady-state adsorption, volume and
concentration of each adsorbate solution were: (1) 15 min, 25 L of 2 mg mL-1
poly(diallyldimethylammonium chloride) (PDDA) in 50 mM NaCl; (2) 20 min, 25 L of
0.1-0.2 mg mL-1 DNA in 5 mM pH 7.1 Tris buffer and 0.50 M NaCl. Final DNA film
architecture was denoted as the order of layer adsorption, (PDDA/DNA) 2. Alternate
adsorption cycles were repeated until the desired number of layers was made. The
number of layers of DNA/PDDA was optimized for the best time-sensitivity ratio. In this
work films with 2 layers of DNA/PDDA ([DNA/PDDA]2 films) were used (Figure 2-5).
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Figure 2-5: Electrochemical experiment design to explore the effect of sperm
centrifugation on sperm DNA damage. Final DNA film architecture is denoted as the
order of layer adsorption; (PDDA/DNA) 2.
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2.2.5.3 Square Wave Voltametry
Square Wave Voltametry (SWV) was performed using CH electrochemical work
station (CH Instruments 440A). The electrochemical cell employed an Ag/AgCl
reference electrode, a platinum wire counter, and a film-coated PG disk as the working
electrode. Unless otherwise noted, the SWV conditions were 4 mV step height, 25 mV
pulse height, and 5 Hz. The electrolyte solution was 10 mM acetate buffer, pH 5.5,
containing 50 mM NaCl and 50 µM Tris(2,2’-bipyridine)ruthenium(II), (Ru (bpy)32+) as
the reporting redox probe.

2.2.6 Statistical analysis
All values were reported as mean ± standard deviation. Difference was considered
significant at P < 0.05 against the control group. Statistical analyses were operated using
one-way analysis of variance (ANOVA) followed by an unpaired Student’s t-test using
the SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.).
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2.3 Results

2.3.1 Effect of sperm centrifugation on sperm motility and viability

Figure 2-6 shows the effect of semen centrifugation (at 220g, 20 min) on sperm
motility and viability. Figure 1A shows the mean values ± standard deviations of sperm
motility for both samples and controls (i.e. without centrifugation). Sperm motility was
significantly different between centrifuged and uncentrifuged samples (24.0 ± 12.8 vs.
33.3 ± 14.2%) (P < 0.05; t-test). In contrast, no significant change was seen in sperm
viability between centrifuged and uncentrifuged samples (34.2 ± 12.6 vs. 39.1 ± 9.7%,
respectively; Fig.1B).
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Figure 2-6: Effect of semen centrifugation on sperm motility (A) and viability (B). Sperm
samples centrifuged 20 min at 1600 rpm; control assayed without centrifugation. Data are
mean values ± standard deviations obtained from analysis of 16 semen samples.
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2.3.2 Effect of semen centrifugation on total antioxidant capacity of seminal plasma

Figure 2-7 shows the effect of semen centrifugation on the total antioxidant
activity (TAC) in seminal plasma as measured by the CUPRAC assay. The absorbance
measured at 450 nm is directly proportional with the TAC of semen sample. We saw an
insignificant difference (P > 0.05, t-test) in average absorbance (0.67 ± 0.08 vs. 0.71 ±
0.09) at 450nm, and thus in total antioxidant capacity of seminal plasma in semen
samples (exposed to 20 min centrifugation at 220g) and the control, Figure 2A. On the
other hand, we observed a significant deacrease in average absorbance (0.78 ± 0.1 vs 0.62
± 0.03) (P < 0.05; t-test) and thus in antioxidant activity in semen samples centrifuged at
forces between 220g and 400g under the same conditions, Figure 2B.

2.3.3 Effect of centrifugation on sperm DNA oxidation as evaluated by flow
cytometry

The effect of centrifugation on sperm DNA oxidation as evaluated by flow
cytometry is shown in Figure 2-8. The flow cytometry analysis of FITC-labeled sperm
showed that the intensity of the FITC fluorescence increased significantly (P < 0.5, t-test)
upon centrifugation of sperm at 220g for 20 min. The intensity of fluorescence,
represented as mean area of FITC-fluorescence ± standard deviation, for uncentrifuged
and centrifuged sperm were 58.5 ± 3.4 vs 210.5 ± 14.8, respectively. This result shows
that the onset of DNA oxidative stress is significant at forces as low as 220g.
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Figure 2-7: Effect of semen centrifugation on total antioxidant activity of seminal plasma as
evaluated by Copper Reducing Antioxidant Capacity (CUPRAC). (A) Sperm centrifuged 20
min at 220g; (B) sperm centrifuged 20 min at 400g. Controls assayed without centrifugation.
The absorbance at 450 nm is proportional to the total antioxidant activity in semen. P-value <
0.05 is considered statistically significant
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Figure 2-8: Effect of centrifugation on sperm DNA oxidation as evaluated by flow
cytometry. Sperm centrifuged 20 minutes at 1600 rpm; control assays without
centrifugation. The X-axis represents the intensity of FITC fluorescence. Data are
representative of 4 independent experiments.
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2.3.4 Effect of centrifugation on sperm DNA oxidation as evaluated by square wave
voltammetry

DNA damage can also be detected through the -now standard- electrocatalytic
oxidation of guanine bases by ruthenium tris-bipyridine as introduced by Thorp et al.[6;
7; 8]. Damaged DNA, with open double helices or broken strands, is expected to provide
the reporter ruthenium redox probe higher access to guanine sites, and thus would
generate oxidation currents commensurate with the extent of DNA damage. This criterion
(i.e. large electrocatalytic currents equivalent to large DNA damage) is used here as such
without explanation of the fundamental concepts, which can be found in numerous
original papers using this method [6; 7; 8]. All DNA damage measurements are carried
out in 10 mM acetate buffer, pH 5.5 solutions containing 50 mM NaCl and 50 M
Ru(bpy)32+ as the reporter probe. All experiments are tripilcates and data points reported
are means of 4 independent experiments.

Figure 2-9 shows the voltametric response of DNA modified electrode for both
centrifuged and uncentrifuged sperm for the desired period of time. As seen in the figure,
an increase in the oxidation current by 17.8% (Icentrifuged sperm/Iuncentrifuged sperm = 1.178), and
thus in sperm DNA oxidative damage, was seen in sperm samples subjected to
centrifugation (220g) compared with the controls (without centrifugation).
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2+

. DNA samples were extracted form sperm

exposed to 20 min centrifugation at 220g; control samples were DNA extracted form
uncentrifuged sperm. Data are representative of 4 independent experiments.
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2.4 Discussion

It has been demonstrated that centrifugation has an adverse effect on sperm
recovery rates [9]. Centrifugation < 330 g for about 15 min had insignificant effect on
sperm motility. However a significant decrease in sperm motility was observed with
centrifugation above 580g at the same length of time [10]. Our study shows that
centrifugation forces as low as 220g for 20 min result in a significant decrease in sperm
motility. We applied a longer centrifugation period (20 min) since this is an IVF protocol
used in many andrology labs. A recent study reported by Lampiao et al. (2010) found that
sperm centrifugation from 10 to 30 min at 400g also decreased sperm motility [11]. Our
results are in agreement with these findings.

In an earlier study, we reported that centrifugation of motile sperm induces the
generation of reactive oxygen species (ROS) [12]. In sperm washing procedures,
depriving the sperm of seminal plasma –their antioxidant reservoir-, is a main
contributing factor behind increased levels of ROS [13]. Induced ROS, mainly hydroxyl
radicals, were shown to affect sperm function and motility [14]. The mechanism by
which the elevated levels of ROS decreases sperm function and motility could be via
increasing sperm’s lipid peroxidation as well as direct oxidation of sperm DNA bases
[14].

The effect of centrifugation on sperm viability was assessed using the one-step
Eosin-Nigrosin test [15]. This test is principally based the membrane permeability for the
supravital Eosin stain. Membrane injury allows the Eosin to enter inside the spermatozoa
and stain it. The intensity of the color is proportional with the magnitude of the damage
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[15]. The unstained spermatozoa (white-colored under the microscope) were considered
viable, while the stained spermatozoa, regardless the intensity of the stain color,
considered non-viable. Our results from this experiment show that viability is not
affected by centrifugation (at least for a 20 min centrifugation period at 220g).

Namik et al. (2000), in their study measured sperm viability after cryopreservationthawing cycles, using annexin V-Cy3 and eosin-Y staining. They noticed a significant
variance between the percentages of sperm accepted as viable between both tests, in
which, Eosin-Y staining test showed lower percent of live sperm compared to the annexin
V-Cy3 test [16]. This variation is attributed to the different mechanisms through which
these tests function. In the present study, we assessed the viability of sperm using the
Eosin stain test that is based on the membrane permeability to Eosin. The mechanism by
which this test categorizes the viable versus non-viable sperm could be a contributing
factor behind the insignificant effect of centrifugation on sperm viability. Using other
reliable viability tests may be needed for conclusive results on the effect of centrifugation
on viability.
As a criterion of oxidative damage exposure, we have adapted the CUPRAC
method, developed by Apak et al. (2008), to measure the total antioxidant capacity
(TAC) in human semen. We used this assay because the reaction is carried out at nearly
physiological conditions. In addition, the CUPRAC method is straightforward and
reliable [1].
At 220g centrifugation force, our results did not show a significant effect of
centrifugation on TAC of semen samples compared to controls. However, we observed a
significant decrease in semen TAC at 400g. It was reported that repeated sperm
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centrifugation, the key step in sperm washing during processing for ART, leads to an
excessive formation of ROS [12]. Along the same lines, a higher centrifugation force
may induce more ROS formation [11]. Accordingly, the increased levels of ROS explain
the decreased TAC that we observed in seminal plasma of sperm subjected to
centrifugation at 400g.
Our flow cytometry experiment was designed to study the effect of centrifugation
(20 min at 220g) on sperm DNA oxidation. Sperm samples were fixed, permabilized and
the DNA oxidation was determined via specific detection of 8-oxoguanines, biomarkers
of DNA oxidative damage, using FITC-labeled conjugate.
The results from this experiment showed an increase in the baseline of sperm
DNA oxidation in the centrifuged sperm compared to the control sample. It instructive to
compare our findings to results obtained by other methods. In this regard, G.D. Smith et
al. reported that Sperm centrifuged during washing steps with HTF show an increase in
the DNA fragmentation using sperm chromatin dispersion assay (SCD) [17]. Our
findings are in line with these findings, and may indicate that the increase in DNA
damage that we observe may be the result of increase in DNA breaks.
In live cells, including sperm, the presence of metal ions, such as ferrous and
cupric ions, and hydrogen peroxide (H2O2) is known to produce hydroxyl radicals
through what is termed as the Fenton reaction [18; 19]. Hydroxyl radicals are highly
reactive oxygen species that induce lesions in DNA bases and deoxyribose sugars in
double helix backbone, which leads to unwinding and DNA fragmentation and breaks
[20].
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In the electrochemical experiment, the Ru(bpy)32+ redox probe reports on exposed
guanine bases in DNA [21]. The Ru(bpy)32+ is oxidized at the electrode surface to
Ru(bpy)33+. In the presence of exposed guanine bases, the oxidized ruthenium probe is
reduced back to Ru (II) state (eq.1), which is again reoxidized at the electrode. This
process produce a catalytic current proportional to the number of exposed guanine bases
[22]. The double-stranded DNA shields guanine moieties from effective contact with
Ru(bpy)33+. Guanine becomes more available after chemical damage occurs in the DNA
this provides more exposure, and thus, access to the resulting catalyst [23].

Ru(bpy)33+ + DNA(guanine)

Ru(bpy)32+ + DNA(guanine+)

(Eq.1)

These results show an increase in the baseline of sperm DNA damage after
centrifugation. This is confirms our results obtained with the flow cytometry method.
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2.5 Conclusion

In summary, semen centrifugation during sperm preparation for ART may
negatively affects sperm quality, via increasing baseline of sperm DNA oxidation and
decreasing seminal TAC and sperm motility. This might be one factor behind the
negative reproductive outcomes such as the increased birth defects among the IVF babies
compared to the normal babies.
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CHAPTER III

L-CARNITINE AS PROTECTIVE MEDIA FOR SPERM IN ASSISTED
REPRODUTIVE TECHNOLOGIES

Summary

In vitro incubation and centrifugation are known to decline human sperm quality.
In our bodies, besides its antioxidant effects, L-carnitine facilitates the transport of the
activated fatty acids from cytosol to the mitochondrial matrix and has antioxidant effects.
Here, we investigated the effect of L-carnitine (LC) on human sperm motility, viability
and DNA oxidation after incubation and centrifugation, following the sperm preparation
protocols of assisted reproduction. Normospermic semen samples (n=55) were analyzed
according to the World Health Organization (WHO) guidelines. LC concentrations that
are not toxic to sperm using sperm motility and viability were standardized after 2- and 4hour incubation at 37°C. Semen samples were also centrifuged for 20 min at 1600 rpm
with the optimized LC concentration and analyzed for sperm motility, viability and DNA
oxidation. Optimal improvement in sperm motility was seen at 0.5 mg/mL LC after
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incubation and centrifugation with 5 X 106 sperm/mL. Higher concentration of LC (50
mg/mL) significantly decreased sperm motility and viability. LC did not alter the baseline
of sperm DNA oxidation during both incubation and centrifugation. In conclusion, LC
may enhance sperm motility following incubation and centrifugation, while it might not
affect sperm viability and DNA oxidation.

3.1 Introduction

Infertility affects one in seven couples who are trying to conceive. Male factor
infertility is involving in up to half of all infertile couples [1; 2]. Decreased semen
quality, a measure of the ability of semen to achieve fertilization, is a primary cause of
male infertility. Usually, poor semen quality is characterized by low sperm motility and
viability. Assisted reproductive techniques (ART) such as intrauterine insemination (IUI),
in vitro fertilization (IVF) with or without intracytoplasmic sperm injection (ICSI) are the
most successful therapeutic means for male factor infertility.

Sperm preparation protocols used in ART involve sperm incubation and
centrifugation. It was reported that sperm motility and viability decrease over time after
ejaculation [3]. Further, a rapid decline in motility was noted after incubating periods
lasting more than 4-hours at 37ºC [4]. A recent study has found that different
centrifugation adversely affects sperm recovery [5]. Increased centrifugation speeds (>
500g) significantly increases the number of dead sperm [6]. Centrifugation has also been
shown to increase the reactive oxygen species (ROS) formation in semen, which may
affect sperm survival [7].
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L-Carnitine (LC) is a naturally occurring molecule, derived from the amino acid
lysine. In cellular systems, LC serves as a facilitator for the transport of activated fatty
acids into the mitochondrial matrix, so that they can be broken down through β-oxidation
to produce ATP [8]. A number of studies have examined the role of LC in reducing the
cellular oxidative stress [9; 10; 11] (figure 3-1). Studies reported an association between
lower levels of LC in semen and male infertility [12; 13]. Dietary supplementation with
LC has been reported to improve sperm quality [14; 15]. Further, a positive correlation
between free LC in human semen and sperm count and motility has been reported [16]. In
addition, it was suggested that LC might be regarded as an index of androgenization [17].
In vitro as well as in vivo studies show that LC decreases the oxidative stress-induced
DNA damage [18; 19; 20]. Furthermore, LC was reported to decrease actinomycin-D,
hydrogen peroxide and TNF-alpha-induced DNA damage and improve the in vitro
blastocyst development rate in mouse embryos [21].

The main goal of this study was first to standardize the LC doses that are not toxic
to sperm, and examine LC effectiveness in improving sperm motility and viability, and
decreasing sperm DNA oxidation induced by in vitro incubation and centrifugation.
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Figure 3-1: LC function. LC facilitates the fatty acid transport into mitochondrial matrix
and has an antioxidant effect.
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3.2 Materials and methods

3.2.1 Sample collection

This study was approved by the institutional review board of Cleveland Clinic
Hospital. Fifty five normozoospermic men were selected and analyzed on the basis of
normal semen analysis according to the World Health Organization (WHO, 1999)
guidelines (section 2.2.1), and used to study the effectiveness of LC on sperm motility,
viability and sperm DNA oxidation during incubation and centrifugation. Samples were
collected by masturbation following a minimum of 48 to 72 hours of sexual abstinence.
Following liquefaction at 37 ºC for 20 minutes, semen specimens were evaluated for
volume, sperm concentration, total cell count, motility and morphology. A 5µL aliquot of
the sample was used for evaluation of concentration and motility using a microcell slide
chamber (Conception Technologies, San Diego, CA).

3.2.2 Effect of various LC concentrations on sperm motility and viability

Sixteen semen samples were examined. Each sample was divided into 6 equal
aliquots; each contained 5 X 106 sperm/ mL. Samples were supplemented with various
concentrations of LC dissolved in phosphate buffered saline, pH 7.4 (PBS). LC
concentrations tested were 0.1, 0.5, 1.0, 10 and 50 mg/mL. The control contained PBS in
place of LC. Sperm motility and viability were assessed after 2 and 4-hours incubation at
37ºC.
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3.2.3 Measurement of sperm viability
Sperm viability was measured by Eosin-Nigrosin staining (see page 25, chapter
II)

3.2.4 Effect of LC on sperm motility and viability during centrifugation
Semen samples (n=19) were divided into two equal aliquots; each aliquot (5 x 106
sperm) was supplemented with 0.5mg/mL of LC dissolved in human tubal fluid (HTF);
control was supplemented with HTF in the place of LC. Sperm motility and viability
were assessed after centrifugation at 1600 rpm for 20 min.

3.2.5 Effect of LC on sperm motility and viability for various sperm concentrations
during sperm incubation
Semen samples from 12 donors were used to examine the optimal sperm
concentration for studying the effects of LC. Sperm concentrations used were 5, 10, 20
and 40 X 106/mL. Each aliquot was supplemented with 0.5 mg/mL LC dissolved in PBS.
Control contained PBS in place of LC. Sperm motility and viability were measured
immediately (time 0) and after 2h incubation at 37ºC.

3.2.6 Effect of LC on sperm DNA oxidation

Oxidative damage to DNA was evaluated using the flow cytometric OxiDNA
assay kit (Calbiochem, San Diego). The assay is based on utilizing a direct fluorescent
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protein binding method targeting oxidized sites in DNA. Briefly, sperm samples were
treated with LC concentration at 0.5 and 50 mg/mL, incubated for 2h at 37ºC, washed
twice in PBS, resuspended in 1% paraformaldehyde at a concentration of 2-4 X 106
cell/mL, and placed on ice for 15 to 30 minutes. Sperm were again washed and
resuspended in 70% ice-cold ethanol by centrifugation at X300g for 5 minutes as per the
kit instructions. The ethanol supernatant was removed, and the sperm pellets were
washed twice in wash buffer and resuspended in 100 µL of the staining solution for 1
hour at room temperature in dark. The staining solution contained FITC-labeled protein
conjugate and distilled water. All cells were further washed using rinse buffer,
resuspended in 250 µL and incubated for 30 minutes in the dark on ice for flow
cytometry measurements. Control samples without LC supplementation were subjected to
the same assay. Negative controls were prepared without FITC staining, while the
positive controls were prepared in the presence of 0.5 mM H2O2 and 0.25 mM FeSO4. To
study the effect of LC on sperm DNA oxidation during centrifugation, sperm samples (5x
106 cell/mL) were treated with one volume HTF supplemented with LC concentration at
0.5 mg/mL, centrifuged for 20 min at 1600 rpm, then submitted to the same treatment as
described above.
Data acquisition was performed within 30 min on a flow cytometer equipped with
a 515-nm argon laser as a light source (FACScan; Becton Dickinson, San Jose, CA).
10,000 cells were examined for each assay at a flow rate of 100 cells/second. The FITC
(log green fluorescence) was measured on FL1 channel. Data analysis was performed
using FlowJo v4.4.4 software (Tree Star Inc., Ashland, OR).
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3.2.7 Statistical analysis
All values were reported as mean ± S.D. Differences were considered significant
at P < 0.05 against control group. Statistical analyses were operated using one-way
analysis of variance (ANOVA) followed by an unpaired Student’s t-test using the
SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.).
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3.3 Results

3.3.1 Effect of LC on Sperm Motility and Viability on Incubation
The effect of various LC concentrations (0.1, 0.5, 1.0, 10, and 50 mg/mL) on
sperm motility and viability was examined after 2 and 4-hour incubation periods at 37ºC
(Figure 3-2). Sperm motility was significantly increased after LC supplementation at 0.1,
0.5 and 1.0 mg/mL after 2 h incubation (55.0% ± 16.9%, 58.4% ± 13.9% and 52.4% ±
19% respectively) compared with the control (39.4% ± 15%; P < 0.05) (Figure 3-2A).
Semen samples supplemented with LC and evaluated after the 4-hours incubation period
did not significantly increase in sperm motility compared with the control (Figure 3-2A).
Semen supplementation with LC did not show a statistically significant increase in sperm
viability at any concentration compared with the control at both incubation periods
(Figure 3-2B). LC concentration of 50 mg/mL significantly reduced sperm motility and
viability compared with the control at the two incubation periods (P < 0.05; Figure 3-2AB).

3.3.2 Effect of LC on Sperm Motility and Viability during Sperm Centrifugation

Figure 3-3 shows the effect of LC on sperm motility and viability after sperm
centrifugation for 20 min at 1600 rpm. Figure 3-3A shows the mean values ± standard
deviations of sperm motility for semen samples centrifuged in presence of LC (0.5
mg/mL) and samples centrifuged in absence of LC (control). A significant difference (P
< 0.05) in average sperm motility (37.5 ± 16.6 vs. 24.0 ± 12.8 %) was observed between
sperm centrifuged with LC compared to the control. The viability was comparable
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between sperm samples treated with LC compared to those without LC treatment (38.0 ±
12.0 vs. 34.2 ± 12.6 %, respectively) (Figure 3-3B).

Figure 3-2: Effect of various in vitro incubation with L-carnitine concentrations
at 37ºC on sperm motility for A: 2h and B: 4 h; viability C: 2 h and D: 4h. Data are mean
values ± standard deviations of sperm motility and viability obtained from analysis of
sixteen different semen samples. P-values for samples and their controls were measured
for all LC concentrations (*P-value < 0.05; **P-value <0.01); P<0.05 was considered
statistically significant.
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Figure 3-3: Effect of centrifugation on A: sperm motility with and without L-carnitine;
B: sperm viability with and without L-carnitine. Sperm aliquots were centrifuged for 20
min at 1600 rpm. All data are mean values ± standard deviations. P<0.05 are considered
statistically significant.

62

3.3.3 Effect of LC on Sperm Motility and Viability for various Sperm
Concentrations

The effect of LC at 0.5 mg/mL concentration on sperm motility and viability was
evaluated for various sperm concentrations (5, 10, 20, and 40 million/mL) (Figure 3-4).
Control samples without LC supplementation were subjected to the same assay
conditions. Motility and viability of sperm were assessed immediately after 2h incubation
at 37°C. Statistically significant increase in sperm motility was observed in semen
samples supplemented with LC compared with the control only for a sperm concentration
of 5 x 106/mL (P < 0.05; Figure 3-4A). No increase in sperm viability was seen after
addition of LC at all sperm concentrations tested (Figure 3-4B).

3.3.4 Effect of LC on Sperm DNA Oxidation

The effect of LC on sperm DNA oxidation during incubation and centrifugation is
shown in Figure 3-5. Flow cytometry analysis of FITC-labeled sperm showed that sperm
treated with the LC at 0.5 and 50 mg/mL for 2h at 37 ºC did not increase the intensity of
the FITC fluorescence, indicating an insignificant effect on the intrinsic baseline of DNA
oxidation (Figure 3-5 A1-A2).
Figure 3-5B shows the effect of LC on the baseline of sperm DNA oxidation
during centrifugation as evaluated by flow cytometry. Sperm samples centrifuged with
LC at 0.5 mg/mL concentration did not show a significant difference in the intensity of
FITC fluorescence, and thus in sperm DNA oxidation, compared to those without LC
supplementation.
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Figure 3-4: Effect of L-carnitine (0.5 mg/mL) on A: sperm motility and B: viability
following incubation with various sperm concentration (5, 10, 20 and 40 X 106/mL
Motility and viability of sperm were assessed immediately after 2h in vitro incubation at
37°C. The histograms are mean values ± standard deviations obtained from analysis of
twelve different semen samples (yellow). Controls (blue) were assayed without addition
of L-carnitine. P-values for samples and their controls were measured for all sperm
concentrations (* P-value < 0.05); P<0.05 was considered statistically significant.
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Figure 3-5: Effect of LC on sperm DNA oxidation during sperm incubation and
centrifugation and evaluated by flow cytometry. A: Sperm incubated for 2h with 0.5
mg/mL (A1) and 50 mg/mL L-carnitine concentrations (A2) at 37ºC. B: Sperm
centrifuged in the presence of 0.5 mg/mL LC for 20 min at 1600 rpm. Sample controls
assayed in the absence of LC in both incubation and centrifugation. Negative controls
were analyzed without FITC staining; positive controls contained H2O2-induced sperm
DNA oxidative damage. The X-axis represents the intensity of sperm-labeled FITC
fluorescence. Data are representative of 4 independent experiments.
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3.4 Discussion
Studies examining effects of LC on sperm quality in general have focused on the
effects of LC in vivo. Recent findings in this context show that administration of LC
might antagonize the oxidative, as well as the pro-inflammatory, pathways that attenuate
sperm motility [15; 23; 24]. In the present study, we have focused on the role of LC in
improving sperm quality in vitro. In the first series of experiments, we standardized the
LC concentrations, utilizing semen from normozoospermic donors and established that
0.1, 0.5 and 1.0 mg/mL concentrations were not toxic. Next, we examined sperm motility
and viability after 2- and 4-hours of incubation.
To study the effect of LC on sperm motility and viability during sperm
centrifugation, we used 0.5 mg/mL LC concentration. Sperm aliquots with and without
LC (control) were centrifuged for 20 min at 1600 rpm. Sperm motility and viability were
then assessed. Our results suggest that LC at the standardized concentrations was
beneficial and improved sperm motility, in particular, after the 2h incubation period. A
significant increase in sperm motility was observed in the centrifuged sperm
supplemented with LC compared to the control. Similar enhancement in sperm motility
in vitro has been reported after adding acetylcarnitine, an acetylated form of carnitine, to
semen at 37ºC [25]. This positive effect of LC on sperm motility is due to its role in
sperm metabolism as well as its antioxidant properties [26; 27]. LC facilitates the
transport of long chain fatty acids across the inner membrane of mitochondria, so that
they can be broken down through β-oxidation to produce ATP [8]; therefore, providing
readily available energy for use by spermatozoa. Accumulation of the reactive oxygen
species (ROS) in sperm leads to ATP depletion, lipid peroxidation and insufficient
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axonemal phosphorylation [28]. The property of LC as a scavenger for ROS could thus
be responsible for its positive effect on sperm motility.
The effect of LC on sperm viability was measured using the one-step EosinNigrosin Test [29]. This test is primarily based on the structural integrity of the
spermatozoa plasma membrane; damage in the membrane provides an access for Eosin to
stain the entire spermatozoa or part of it based on the size of the damage [29]. A stained
spermatozoa is considered non-viable, while the unstained one is counted as viable.
LC contributes in shielding sperm membranes against harmful ROS because of its
antioxidant activity [27]. It also decreases the availability of lipids for peroxidation via
easing the transport of fatty acids to the mitochondrial matrix for β-oxidation [30].
Neuman et al. (2002) reported that dietary supplementation with LC reduces sperm lipid
peroxidation in roosters; this may preserve sperm membranes, thereby increasing their
viability [31]. We therefore anticipated that semen supplementation with LC would
improve sperm viability. Contrary to our expectation, we observed that semen
supplementation with LC showed only a slight but statistically insignificant effect in
improving sperm viability during incubation. Similar insignificant effects were reported
earlier by Namik et al. (2000) who studied the influence of acetyl-L-carnitine on sperm
membrane damage after cryopreservation-thawing cycles [32]. Similarly, using in vivo
systems, it was found that dietary supplementation with LC did not improve the
membrane integrity of pony stallion sperm [33]. A more recent study by Yeste et al.
(2010) showed that the addition of LC to the diet of boar males had no effect on their
sperm viability [34]. In contrast, De Rosa et al. (2005) noted that LC administration to
infertile human males with poor sperm motility (<50%) was effective in improving
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membrane integrity of the ejaculated sperm. In our in vitro study, we only added LC to
semen samples with normal motility (>50%). A similar in vitro study, utilizing semen
samples from infertile subjects is needed to assess LC effect on sperm viability during
incubation and substantiate our findings.
Namik et al. (2000) used two assays eosin-Y staining and annexin V-Cy3 in their
study to measure sperm viability after cryopreservation-thawing. These investigators
observed significant discrepancy between the percentages of sperm marked as “live”
between eosin-Y staining and annexin V-Cy3 assay. The eosin-Y staining showed lower
percent of viable sperm compared to the annexin V-Cy3 assay [32]. These investigators
attributed this discrepancy to the different mechanisms through which these assays
operate. In our study, we measured sperm viability using the eosin-staining assay, which
is based on the membrane permeability for the eosin stain. Therefore, the mechanism by
which this assay recognizes live sperm could be a contributing factor in this insignificant
effect of LC on sperm viability.
The influence of LC on sperm motility and viability of various sperm
concentrations was also investigated (Figure 3). We supplemented different
concentrations of sperm with LC at 0.5 mg/mL. Our results from this experiment suggest
that LC was effective in increasing sperm motility only when utilizing sperm
concentration of 5 x 106 cell/mL. At higher sperm concentrations, the decrease in the
ratio of the sperm number against available LC molecules may explain the lack of effect
in improving the sperm motility. On the other hand, sperm viability did not increase
utilizing any of the sperm concentrations. These results are in agreement with our
experiment above. This information may be exploited in exploring and designing
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protocols that aim to improve sperm motility in patients with low sperm count and
especially oligozoospermic patients.
LC has been shown to improve resistance to oxidative stress by decreasing DNA
damage in Ataxia telangiectasia cells [35]. Moreover, Thangasamy et al. (2009) reported
that LC significantly reduces DNA damage in lymphocytes of aged rats [18]. We also
recently demonstrated the effectiveness of LC in reducing H2O2-induced DNA damage
and improvement of in vitro blastocyst development rate in mouse embryos [21]. In the
present study, we examined if LC had similar effects on human sperm DNA in vitro. We
incubated the sperm samples with the standardized LC concentration 0.5 mg/mL, at 37ºC
for 2h. We did not see the decrease in the extent of the sperm DNA oxidation (Figure 35-A1). Similarly, we did not see a significant effect of LC on the baseline of sperm DNA
oxidation after centrifugation compared with control samples (i.e. centrifugation without
LC) (Figure 3-5-B).

Studies in vitro show that semen supplementation with an antioxidant does not
affect sperm DNA integrity. In fact, Donnelly et al. (1999) showed that neither addition
of ascorbate nor addition of α-tocopherol to sperm preparation medium affected DNA
integrity of sperm. However, both antioxidants provided protection against the H2O2induced DNA damage in sperm [36]. Similar reports showed that addition of vitamin E to
cryopreservation medium did not alter the post-thaw DNA fragmentation of sperm [37].
These results are in line with our observations, which don’t show a significant effect of
LC as an antioxidant LC in reducing DNA oxidative damage in sperm.
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Very low concentrations of LC have been reported in azoospermic men compared
with normospermic control [38]. Further, lower concentrations of LC were noted in
oligoasthenozoospermic males, and LC supplementation was shown to improve semen
quality in these people [39]. One explanation for the undetectable effect of LC on sperm
DNA oxidation may be the fact that we used only semen samples from normozoospermic
subjects in our study. Furthermore, contrary to majority of reported studies [21; 23; 35;
36], we measured the effect of LC on the baseline levels of oxidative DNA damage in
sperm without any induction of oxidative damage as in other studies this might be
another likely reason for the lack of significant effect of LC on sperm DNA oxidation.
Another reason for lack of improvement in DNA oxidation may be the fact that
mammalian sperm DNA is highly compacted (six-fold more highly condensed) compared
to DNA in somatic cells [40]. Also, the majority of antioxidants in somatic cells are
present within their cytoplasm, while in sperm, a significant amount of the antioxidants
are present in seminal plasma outside the sperm because spermatozoa lose most of its
cytoplasm during maturation [41]. Therefore, the differences in the DNA packaging and
the distribution of antioxidants between spermatozoa and somatic cells might introduce
variations in outcomes when measuring the effect of in vitro supplementation of
antioxidants on DNA oxidation.

Given that LC is a substantial antioxidant [27; 42], the role of antioxidant therapy
in improving male fertility could be a double-edged sword with unfavorable effects if the
safety threshold dose is exceeded [42]. For example, extreme levels of the known
antioxidant L-ascorbic acid are thought to be associated with a decline in fertility [43],
even though it is the principal antioxidant in seminal plasma of fertile males [44]. Further
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research is needed before the role for antioxidants in the treatment of male infertility is
established [45]. The in vitro studies on human sperm by Donnelly et al. (1999) showed
that higher concentrations of L-ascorbic acid (> 20 µM) negatively affect sperm motility
in both normozoospermic and asthenozoospermic samples. Our findings are in agreement
with this concept, and we have shown that sperm quality in vitro is lower at high
concentrations of LC.

It has been shown that cell treatment with high concentrations of antioxidants in
vitro increases the levels of 8-oxoguanine moieties on DNA, a biomarker for DNA
oxidative damage [46]. Increasing DNA oxidative damage may lead to apoptosis and cell
death [47; 48]. We therefore examined if high LC concentration decreased in vitro sperm
quality by inducing sperm DNA oxidation. We measured the 8-oxoguanine moieties in
the sperm DNA after incubating the sperm with 50 mg/mL LC using flow cytometry. Our
results suggest that this might not be the likely mechanism by which the high LC level
affects negatively sperm quality in vitro (Figure 3-5-A2). Again, the fact that we used
samples from normozoospermic subjects may contribute to the absence of significant
effects in our work.

In conclusion, LC enhances sperm motility following in vitro incubation and
centrifugation, while it might not significantly affect sperm viability and DNA oxidation
baseline of sperm. Our results provide a solid ground to explore and design protocols to
test potentially beneficial effect of LC supplementation for sperm prepared for ART.
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CHAPTER IV

NITRIC OXIDE IN HUMAN MALE REPRODUCTION

Summary
In this chapter, we provide a literature review of the role of nitric oxide (NO), one
of the main reactive oxygen species, in human male reproduction. The goal of this review
is to enrich our understanding of the molecular basis of the function of NO in human
spermatozoa. In the beginning of this chapter, we discuss nitric oxide synthesis and
mechanisms of action and function in cellular systems. Then, we provide a
comprehensive literature review of the role of NO in human spermatozoa physiology and
function, as well as its contribution as a marker in male infertility diagnosis. In addition,
we provide an in-depth review of NO antagonistic effects on spermatozoa function and
physiology. Moreover, we review the methods that are commonly used to measure NO in
semen. The collective information from this literature survey points to the fact that some
level of NO is vital for human sperm function and physiology and mainly for the motility
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of spermatozoa. However, increased levels of NO are considered detrimental to
spermatozoa and contribute to male infertility.

4.1 Nitric oxide, function and synthesis
Nitric oxide (NO) is a diatomic free radical. It is similar to oxygen in its
maximum solubility in water. NO is also a non-polar molecule and able to diffuse easily
through cellular membranes [1]. One of the most distinctive chemical features of NO is
that it is paramagnetic, does not have a tendency to make dimers

at the standard

conditions [2].
Currently, it is one of the extensively studied species in biomedicine because of
its various functions in biological systems. It has been referred to as the endotheliumderived relaxing factor (EDRF) because it causes vasodilation via a cascade that leads to
vascular smooth muscle relaxation [3; 4; 5]. In addition, nitric oxide prevents platelets
aggregation [6], acts as a neurotransmitter [7; 8], and mediates macrophage bactericidal
activity.
Reports have shown that NO has a major contribution in human reproduction. It is
recognized as a key molecule in controlling hypothalamic-pituitary-gonadal axis [1]; it
activates the release of luteinizing hormone-releasing hormone (LHRH), which triggers
the pituitary gland to release the gonadotropins via activating nNOS in the pituitary [9].
In the gonad, it has a central role in inducing ovulation in human’s female and in causing
luteolysis [9]. NO has also a significant contribution in human’s sexual behavior; in
males, it induces the erection via generating cyclic guanosine monophosphate (cGMP) in
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corpora cavernosa [10]. In females, it relaxes vaginal smooth muscle and induces vaginal
secretions [9].

Figure 4-1: Synthesis of nitric oxide.
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NO is synthesized by a family of enzymes called nitric oxide synthases (NOSs)
from the oxidation of arginine. NO is released after a two-step catalytic cycle along with
citrulline as a byproduct. O2 and NADPH, the reduced form of nicotinamide adenine
dinucleotide phosphate, are required in this reaction (figure 4-1). Flavin adenine
dinucleotide (FAD), flavin mononucleotide (FMN), and tetrahydrobiopterin, are also
needed for the NOS reaction [11]. In tissues, NO has a very short half-life (3 to 10
seconds) because it reacts with oxygen (O2) and and converts into nitrite and nitrate. It
also reacts with superoxide ion (O2-.)

and thiol sites to yield peroxynitrite and

nitrosothiols respectively.

4.2 NO synthases
Three isoenzymes of NO synthase have been identified. Endothelium NOS
(eNOS), primarily present in endothelium, neuronal NOS (nNOS), primarily present in
neural tissue, and inducible NOS (iNOS), can be expressed in various cells such as
macrophages, monocytes, neutrophils and hepatocytes [11; 12].
The isoforms eNOS and nNOS are constitutive, synthesized usually at a steady
rate in spite of physiologic need, and Ca2+-calmodulin-dependent enzymes [11; 12] .
iNOS is a Ca2+-independent enzyme;

it has specific inducers (e.g. inflammatory

cytokines, tumor necrosis factor, bacterial endotoxins) which vary by cell type. These
inducers increase iNOS synthesis, which can result in a large amount of NO being
formed [13; 14; 15].
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4.3 NO and smooth muscle contraction:
In endothelial cells, NO is synthesized by eNOS and diffuses into vascular smooth
muscle (VSM), and activates the cytosolic –soluble- guanylate cyclase (sGC), which
increases the production of cGMP, and consequently, protein kinase G (PKG). PKG then
phosphorylates myosin light-chain kinase and leaves it inactive, thereby lowering smooth
muscle contraction.

4.4 Nitric oxide mechanisms of action mediated by peroxynitrite
In biological systems, peroxynitrite, which results from the combination of NO
with superoxide ion (O2-.), is a double-edged sword anion. It has both beneficial and
detrimental actions. These actions, endogenous and exogenous, are mostly due to
oxidation and nitration reactions with other biomolecules, mainly proteins, lipids and
nucleic acids (Figure 4-2) [16]. The effects of peroxynitrite could be both direct and
indirect. For example, peroxynitrite produces small concentrations of secondary NO
when reacting with other biomolecules and promotes vasodilation, inhibition of platelet
aggregation and hypotension [17].

1. Role in bactericidal activity
Normally, iNOS activity in macrophages is not high. In response to infection, by
the effect of interferon-alpha and bacterial lipopolysaccharides (LPS), its synthesis
increases resulting in higher NO production. NO combines with O2-.

and form

peroxynitrite (ONOO-), which, among other reaction pathways, breaks down in the
presence of hydrogen ion into HO., a highly bactericidal radical (scheme 1).
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Scheme 1: Formation of hydroxyl radical from nitric oxide.
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2. Effects on proteins and enzymes
Various proteins in humans and other biological systems are targets for
peroxynitrite attacks. Oxidation and nitration of proteins may down-regulate the positive
feedback cycles of injury and decreases the ability of the cell to fight against free radical
damage. This will lead to antioxidant depletion, oxidative stress, and consequently, cell
necrosis or apoptosis. Such cases are more likely when peroxynitrite attacks antioxidant
enzymes such as the superoxide dismutase and glutathione reductase, as well as, other
species of antioxidant defense mechanisms like glutathione and cysteine [16; 18-22].
Inhibition of cytosolic as well as membrane proteins and enzymes because of
peroxynitrite attack leads to impairment of cell function, and subsequently disease onset
(Table 4-1).

3. Lipid oxidation and nitration by peroxynitrite
The decomposition of peroxynitrite, in the presence of hydrogen ion, to form •OH
and •NO2 may initiate lipid peroxidation when it occurs in hydrophobic phases [16; 23].
The reaction results in Lipid peroxidation products such as malondialdehyde,
hydroperoxide and conjugated diene [23], as well as in the nitro, nitrito-, nitrosoperoxoand nitrated lipid oxidation products. Low-density lipoprotein (LDL) is also a target for
peroxynitrite insult. LDL oxidation by peroxynitrite leads to the formation of F2isoprostanes [16; 24], a family of prostaglandin-like compounds formed via nonenzymatic lipid peroxidation.

Fatty acids nitration may secondarily inhibit protein

function through thiol modifications [25]. Conversely, nitrated lipids can have anti-
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inflammatory functions via peroxisome proliferator-activated receptor gamma (PPARγ)-dependent and independent pathways [16; 26].

4. Effect on DNA
DNA is also another target for peroxynitrite and its derived radicals. They can
cause DNA base modification; for example, 8-oxoguanine and 8-nitroguanine are main
products of purine oxidation [27]. Furthermore, it can activates Ca2+-Mg2+endnonucleases [16]. In addition, peroxynitrite can oxidize deoxyribose sugar and lead to
double and single strand breaks [16; 28]. Such DNA injury may lead to genotoxic
damage, which may develop into pathological disorders. Peroxynitrite may also induce
secondary DNA repair and activate the suicidal pathway including poly ADP-ribose
polymerase activation (PARP-activation), and consequently cell necrosis (Figure 4-2)
[29].
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Table 4-1: Examples of cytosolic and membrane enzymes and proteins affected by
peroxynitrite (adapted from Casaba Szabo et al., 2007).

Enzyme or protein
Glyceraldehyde-3phosphate
dehydrogenase
Tyrosine hydroxylase

Creatine kinase

Mechanism of action Consequences and related
health disorders
Oxidation of cysteine Impairment of cellular
residues
function

Ref.

Nitration of tyrosine
residues

[31]

Impaired the production of
dopamine in the
dopaminergic neurons (e.g.
in Parkinson disease)

Impairment of myocytes
function, which may leads to
myocardial infarction or
chronic heart failure.
Tyrosine nitration and Impairment of cellular
cysteine oxidation
calcium handling and
cellular ionic balance, which
is linked with heart failure.

[16;
32]

Epidermal growth
factor receptor (EGF)

Dimerization,
nitration and
oxidation

[16;
35]

Prostacyclin synthase

Oxidation and
nitration

Cellular signaling
impairment including a
possible pathway leading to
insulin resistance
Prostaglandin formation
inhibition.

Alpha-synuclein and
microtubule related tau
protein modification in
CNS

Nitration and
oxidation

Initiation pathogenesis of
alpha-synuclein aggregates

[16;
37]

Calcium pumps:
including
sarco/edoplasmic
reticulaum Ca2+ATPase (SERCA)

Oxidation of cysteine
residues

[30]
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[33;
34]

[36]

Figure 4-2: nitric oxide actions mediated by peroxynitrite.
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5. Effect on NOS cofactors
Peroxynitrite can impair enzymatic cofactors directly or indirectly via free
radical-dependent mechanisms. It can oxidizes tetrahydrobiopterin (BH4) (Figure 4-3), a
cofactor of NOS enzyme that serves as an electron relay for timed redox reactions used in
oxygen activation. The oxidation of BH4 leads to the inactive form quinonoid 5,6dihydrobiopterin [38] which is subsequently converted to 7, 8-dihydrobiopterin. This
oxidation affects negatively the function of NOS, and thus NO production [16]. Milstien
and Katusic (1999) have suggested that abnormally low concentrations of BH4 may
promote a cycle of its own destruction arbitrated by NOS-dependent formation of
peroxynitrite; such mechanism might have a contribution in vascular endothelial
dysfunction stimulated by oxidative stress [38].
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Figure 4-3: Chemical structure of tetrahydrobiopterin (A), and 7, 8-dihydrobiopterin (B).
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4.5 Nitric oxide and male infertility
Studies have shown that NO has a major contribution in male reproduction [3944]. Higher levels of nitric oxide were recognized in the semen of infertile men compared
to fertile [42]. It was found that NO generation is very important in gamete interaction
and fertilization route [45]. Xu et al. (2008) studied the relationship between nitric oxide
synthase and nitric oxide with varicocele-based infertility; they found that NO mediates
the decrease in semen quality induced by varicocele [46]. A recent study reported that the
missense Glu298Asp polymorphism of eNOS gene is present at a higher frequency in
infertile asthenozoospermic subjects [47].
Supplementation

of

asthenozoospermic

infertile

men

ejaculates

with

Ginsenoside R (e) improves human’s male fertility by increasing sperm motility [48].
The mechanism by which this occurs may involve NOS stimulation and enhanced NO
synthesis [48]. Huang et al. (2006) studied the correlation between NO levels and sperm
morphology; they found that low concentrations of NO are associated with defects in
sperm morphology [49]. A very recent study showed that increased levels of NO is linked
with

a

decrease

in

sperm

function

in

asthenospermia,

normospermia

and

leukocytospermia, whereas, lower levels of NO may contribute in the etiology of
oligospermia [50].

4.6 Nitric oxide synthases in human spermatozoa
NOSs are ubiquitous, present in almost all tissues of the human body [51]. NOS
activity has been verified in human testes, seminal vesicles, and prostates [52]. These
findings imply a possible function of NO in spermatogenesis and the maturation of
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sperm. It has been recognized that nitric oxide synthase (NOS) is present in human
spermatozoa and NO production at endogenous levels is very important for adequate
sperm function [48; 51; 53-55]. Lewis et al. (1996) reported that human spermatozoa
express eNOS as well as nNOS [53]. At a later date (1998), Moria et al. confirmed that
human spermatozoa express eNOS. The same group, using immunohistochemistry,
detected the presence of eNOS in sperm and showed that the majority of sperm display
postacrosomal and equatorial eNOS staining (head and midpiece). In 2000, Francavilla et
al. concluded that constitutive NOS (eNOS and nNOS) plays a role in the capability of
human sperm to fuse with oocyte in the zona pellucida (ZP), a glycoprotein membrane
that surrounds the plasma membrane of an oocyte. They showed that inhibited
constitutive NOS activity using NG-nitro-l-arginine methyl ester (L-NAME) significantly
decreased the oocyte fusion without affecting the ZP binding [56]. Newly published
study showed that increased NOS activity is present in mature sperm compared to
immature [57].
NOS activity was also studied in seminal plasma. Both calcium-dependent NOS
activity as well as calcium-independent NOS activity were detected in human seminal
plasma [58]. There was no association between NOS activity in seminal plasma and
sperm motility and concentration [58]. Later, another study supported these findings by
showing that seminal plasma nitrite does not correlate with sperm count and rapidforward motility [59]. In addition, positive sperm culture did not increase the
concentration of nitrite in seminal plasma [59].
On a related front, mRNA transcripts of eNOS and nNOS have been detected in
semen samples, and they have a clinical significance in the diagnosis of fertilization [60].
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For example, eNOS and nNOS transcripts were present in low motile sperm samples,
while they are undetectable in the high motile ones [60].

4.7 Nitric oxide and sperm motility
Flagellum beating is very important to sperm motion; defects in sperm motility
leads to infertility and ectopic pregnancy [61]. Several studies showed that NO
production at endogenous levels is very important for adequate sperm motion [48; 51; 5355]. Insulin, a central hormone in regulating carbohydrate metabolism in the human
body, and leptin, an adipose-derived hormone, significantly increased in vitro motility
and nitric oxide production in sperm [15] (Figure 4-4). Ankri et al. (2009) proposed that
exposure of human spermatozoa to visible light may increase NO formation, which
enhances the motility of sperm, and thus the rate of fertilization. According to the same
group, this effect may be attributable to increase of light absorbance by the NOS
coenzymes flavin and heme. Lately, an in vitro study observed that adding L-arginine to
asthenospermic patient’s semen samples increases NO production and sperm motility.
This effect happens only in the presence of an active anion transport system [62].
It was also reported that sperm recovery is also altered upon using dissimilar
methods to prepare sperm in vitro. Ding et al. (2002) used two different methods, Percoll
and IxaPrep, to prepare human sperm in vitro and they found that the IxaPrep method
provides a better recovery rate of sperm. They concluded that the better sperm quality by
the IxaPrep method may be the result of decreased levels of NO generated, because
increased levels of nitric oxide affects negatively the quality of the sperm [63].
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Figure 4-4: various compounds and factors increase sperm motility may be by increasing
NO production.
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4.8 Nitric oxide mechanisms of action in human sperm
Miraglia et al. (2010) showed that NO stimulates human spermatozoa motility by
activation of soluble guanylate cyclase (sGC), subsequent production of cyclic guanosine
monophosphate

(cGMP)

and

activation

of

cGMP-dependent

protein

kinases

(cGMP/protein kinase G signaling pathway) [64]. An earlier study suggested that NO
induces acrosomal reaction in human spermatozoa via stimulating sGC, cGMP, and PKG
activation, and extracellular Ca2+ is required in this activation [65].
Alternatively, by a mechanism that does not require sGC activation; L. Lefievre et
al. (2007) demonstrated that many proteins (signaling, regulatory, kinases, receptors,
transport, structural and others) in human spermatozoa are possible targets for Snitrosylation, a dynamic mechanism analogous to phosphorylation in which a nitrosyl
group is added to a protein (25). In general, S-nitrosylation by nitric oxide is very
important reaction in biological systems; it refers usually to the conversion of thiol
groups, involving cysteine residues in proteins, to S-nitrosothiols, such examples are
shown above (Table 4-1) (26, 27).
A subsequent study reported that NO has a key function in the gamete interaction
and fertilization within human female’s tract. It regulates the mobilization of stored Ca2+
ions in human spermatozoa via protein S-nitrosylation, which ultimately lead to the
regulation of flagellar beating. This action is synergistic with the action of progesterone
(Figure 4-5) [66]. The pre-treatment of sperm with NO increased significantly the effect
of progesterone on intracellular free calcium ions, possibly by binding on a membrane
surface receptor, which activates Ca2+ influx using a plasma membrane channels [45].
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Increasing intracellular Ca2+ induces mobilization of stored calcium via a Ca2+-induced
Ca2+ release process (CICR).
On another front, reports have shown an association between apoptosis
mechanisms in sperm and NO synthesis. For example, activation of apoptosis signaling in
human spermatozoa is negatively correlated with NO production [57].

4.9 Role of nitric oxide in human sperm capacitation and acrosomal reaction
Sperm capacitation is an ultimate biochemical event that occurs typically in the
female’s reproductive tract after ejaculation. It is required for the spermatozoa to be
competent for oocyte penetration. A number of studies reported that NO is important for
human sperm capacitation [67; 68; 69]. It was indicated that NO is formed by
capacitating human spermatozoa [70]. NO may act as a messenger via modulating the
cAMP/protein tyrosine phosphorylation pathway involved in spermatozoa capacitation
[70]. Herrero et.al. (2001) emphasized that capacitation is part of an oxidation process
that involves NO. They demonstrated that the nitration of tyrosine in sperm proteins by
NO takes place in capacitated human spermatozoa [71]. Later study found that NO
regulates the phosphorylation of threonine-Glutamine-Tyrosine motif in human
spermatozoa proteins of 80 and 105 kDa through capacitation [72]. Others have shown
the effect of Ginsenoside Re, a bioactive component from ginseng, on sperm capacitation
and acrosomal reaction occurs through NO-dependent cGMP/ protein kinase G signaling
pathway [73]. De Lamirande and Lamothe (2009) showed a close interaction between
NO and superoxide ion (O2-•) during human sperm capacitation is needed for acquisition
of fertility [69]. Inhibition of NO generation as well as other ROS by semenogelin, the
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predominant protein in human semen, blocks sperm capicitation [74]. On the other hand,
nitric oxide at low concentrations increased human sperm capacitation through
enhancement of sperm-zona pillucida (ZP) binding capacity [75].
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Figure 4-5: Synergistic effect of NO and progesterone (modified from Linda et al.,
2009).
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4.10 Adverse effects of NO on sperm physiology and function
It has been shown that NO is vital for appropriate sperm function, while
overproduction of this reactive free radical has also pathologic implications, particularly
on the motility of sperm [55]. Induced oxidative stress to human sperm in vitro using
high doses of H2O2 showed a significant increase in NO levels and a significant decrease
in sperm motility [55; 76]. Rosselli et al. (1995) found that higher levels of nitric oxide
decrease the quality of sperm in vitro [40]. Later study on varicocele suggested that nitric
oxide synthase released within the dilated spermatic vein establishes a high oxidative
stress state as a result of increased production of NO. Formation of peroxynitrite from the
reaction of NO with superoxide ion also affects sperm function in varicocele patients
[77]. On the other hand, no significant relationship was found between NO
concentrations and the severity of athenozoospermia, oligoospermia, and abnormal sperm
morphology in these people [78].
Treatment of purified spermatozoa with NO-doses from NO-donors such as Snitroso-N-acetylpenicillamine and sodium nitroprusside decreased both sperm motility
and viability [40; 42; 79]. The nitric oxide generator, SIN-1 (3-morpholinosydnonimine
hydrochloride), was used as a spermicidal agent [80]. Adding the calcium ionophore
A23187, an activator of both eNOS and nNOS, to human sperm medium increased
significantly the production of NO [54] and, as a result, decreased sperm motility. Others
showed that the overproduction of NO in the genital tract of infertile human subjects
decreases the integrity of sperm DNA [81]. A later study demonstrated that TNF-alpha
and IL-6, two cytokines involved in inflammation, decrease sperm motility possibly via
inducing NO formation [82].
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In contrast, melatonin (N-acetyl-5-methoxytryptamine), a hormone secreted by
pineal gland and responsible for circadian rhythm, is able to scavenge directly and
indirectly NO in human sperm. Accordingly, it was concluded that supplementation of
sperm medium with melatonin might be able to counteract the adverse effects of NO on
sperm [83].

4.11 Measurement of NO in semen
The most common method used to measure NO in human semen is nitrite
colorimetric assay, also known as the Griess assay. In this assay, NO is assessed
indirectly via measuring its breakdown product nitrite (NO2-), formed by spontaneous
oxidation of NO [84]. The detection limit for this assay is 1 μM nitrite [84]. Sulfanilic
acid first reacts with NO2-, in the semen sample to produce an intermediate diazonium,
which then reacts with N-(1-naphthyl) ethylenediamine and form a stable azo dye, which
absorbs light at 540nm [85]. To accurately measure all nitric oxide produced in the
sample, some reports first convert all nitrate to nitrite using nitrate reductase enzyme,
before using the Griess assay [85].

Chemiluminescence is another method commonly used to determine NO in
semen. The detection is based on NO reaction with ozone (O3), which leads to red light
emission (Scheme 4-2). Photons detected from this reaction, using a photomultiplier tube
are transformed to an electrical signal that is proportional to the amount of measured NO
[63].
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Scheme 4-2: reaction of NO with ozone.

Others have used other techniques to measure NO production at cellular level
such as electron paramagnetic resonance (EPR) spectroscopy and spin trapping [70].
Such techniques are not commonly used in the andrology laboratories because they are
more complicated and not readily available to common andrology laboratories [86; 87].
In the following chapter, we have standardized a direct method to measure nitric oxide in
human spermatozoa using flow cytometry.
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4.12 Conclusion
Nitric oxide synthases, mainly the constitutive isoforms, are present in human
spermatozoa. Physiologic levels of NO are vital for human sperm function and
physiology, mainly for adequate flagellar beating and progressive motion. The effects of
NO on human spermatozoa could be direct or indirect (mediated by peroxynitrite and/or
its derivatives). Decreased levels of NO impair the function of spermatozoa. Likewise,
excessive levels of NO contribute to oxidative stress and are detrimental to sperm quality.
Although the evidence cited in this chapter shows that NO is very important for human
sperm quality such as adequate sperm motility, many of its roles and mechanisms of
action in sperm are yet to be fully unveiled.
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CHAPTER V

A NEW METHOD FOR MEASUREMENT OF NITRIC OXIDE PRODUCTION
IN HUMAN SPERMATOZOA USING FLOW CYTOMETRY

Summary

Studies showed that nitric oxide (NO) has a major contribution in male
reproduction. However, many of NO’s mechanisms of action in sperm remain unclear;
one important reason is that methods for direct NO measurement at the level single cells
and/or collections of cells are not straightforward. Here we demonstrated a method to
measure intracellular NO in human sperm by means of flow cytometry using NO-specific
probe 4,5-diaminofluorescein-2-diacetate (DAF-2DA). Motile sperm are freshly prepared
using a modified direct swim-up procedure. Both sperm and DAF-2DA concentrations
are standardized. Sperm samples incubated with L-nitro-arginine methyl ester (LNAME), a Nitric Oxide Synthase (NOS) inhibitor, showed lower fluorescence in a dosedependent manner. Sperm samples supplemented with Diethylamine NONOate (DEA
NONOate), a nitric oxide donor, showed higher fluorescence compared to the control. At
last, we used this method to measure the effect of L-carnitine, a motility stimulant as we
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have showed in the third chapter, on NO production in human spermatozoa. We found
that LC may increases sperm motility via increasing the production of NO.

5.1 Introduction

Nitric oxide (NO) is one of the most studied molecules in biomedicine because of
its various physiological functions. As we have reported in the previous chapter, it has
been referred to as an endothelium-derived relaxing factor because it causes vasodilation
via relaxing vascular smooth muscle [1; 2; 3]. In addition, it prevents platelets
aggregation [4], acts as a neurotransmitter [5; 6], and mediates macrophage bactericidal
activity [7].
Reports have shown that NO has a significant involvement in male reproduction
[8; 9]. Various studies showed that endogenous NO is very important for sperm motion
[10- 14]. NO generation was found to be crucial in gamete interaction and fertilization
route [15]. A number of studies reported that NO is involved in human sperm
capacitation [16; 17; 18]. In contrast, others have shown that higher levels of nitric oxide
were observed in infertile men compared to control groups [19].
Although the evidence above points to the fact that NO is very important for
human sperm physiology and function, its exact mechanisms of action in sperm are yet to
be fully understood. The majority of measurement of NO in sperm relied on nitrite
determinations using colorimetric assays. This may not relay an accurate picture on NO
concentration and its fluctuations in spermatozoa. Methods that have the potential to
follow NO concentration under varying conditions within cells are of particular
importance to investigate the mechanisms of actions of NO in sperm function.
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Analysis by flow cytometry has entered many andrology laboratories and has
been used to evaluate sperm count and viability [20], to detect antisperm antibody [21;
22] and to study the chromatin structure of sperm [23]. The considerable advantage of
flow cytometry is that millions of cells can be analyzed in seconds, providing a
statistically more precise assessment of the level of analyte under consideration. Here, we
demonstrated a method to detect the intracellular NO in human sperm using the NOspecific probe 4,5-diaminofluorescein-2-diacetate (DAF-2DA). The specific detection of
NO and the sensitivity of fluorescence are coupled to the high throughput capability of
flow cytometry; this provides a specific, sensitive, and fast method of monitor NO
concentration in spermatozoa under varying experimental conditions.

5.2 Materials and methods
Sample collection

Our study was approved by the institutional review board of Cleveland Clinic
Hospital. Normospermic men were selected and analyzed based on normal semen
analysis according to the World Health Organization (WHO) (1999) guidelines (section
2.2.1). Fresh semen samples were used to standardize the measurement of intracellular
NO in sperm using DAF-2DA by means of flow cytometry.
Samples were collected by masturbation following a minimum of 48 to 72 hours
of sexual abstinence. Following liquefaction at 37 ºC for 20 minutes, semen specimens
were evaluated for volume, sperm concentration, total cell count, motility and
morphology. A total amount of 5µL of the sample was used for evaluation of
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concentration and motility using a microcell slide chamber (Conception Technologies,
San Diego, CA).

Preparation of motile sperm samples
Motile sperm were retrieved from semen samples using direct swim-up technique.
This procedure was adapted from the one described by World Health Organization (1999)
(section 2.2.1). Briefly, spermatozoa are selected based on the ability to swim out of
seminal plasma into the human tubal fluid (HTF). We use only untreated, fresh semen in
this process. 0.8 ml of homogenized semen was pipetted carefully under 1 ml of HTF
placed in a 15 ml conical centrifuge tube while avoiding the mixing between the semen
and the supplemented medium. Afterward, the tube was left at 90º angle for 1 hr at 37ºC.
The uppermost (~ 0.6 – 0.8 µL) medium containing only the highly motile sperm is
transferred to another test tube, and centrifuged for 4 min at 1600 rpm. Then, the top
layer was discarded, and the sperm in the bottom resuspended in 0.5 mL HTF. The
resulting motile sperm are washed and their concentration adjusted as needed.

DAF-2DA preparation
DAF-2DA was dissolved in dimethyl sulfoxide (DMSO) because it has a very low
solubility in water. Although DMSO is a very suitable solvent for DAF-2DA, it is
considered toxic to human sperm when added at higher concentrations [24]. Therefore, in
our experimental design, we added DAF-2DA/DMSO solution to sperm medium at a
concentration of ≤ 5% (v/v). We did not see a statistical difference in sperm viability
after adding DMSO of ≤ 5% (v/v) compared to sperm without DMSO (Figure 6-5). We
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run our experiments in the dark conditions in order to avoid the exposure of DAF-2DA to
the light, because fluorescein can be easily photobleached, a photochemical destruction
of the fluorophore [25] .

Measurement of DAF-2T fluorescence at various sperm concentrations
The concentration of washed motile sperm is adjusted with HTF to within 0.5- 8.0
x 106/ mL range. The samples (n=6) are then supplemented with 20 µM of DAF-2DA,
incubated for 90 min at 37 ºC in dark, and analyzed with flow cytometry. Identical
samples without addition of DAF-2DA are used as controls.

Measurement of DAF-2T fluorescence at various DAF-2DA concentrations
Samples (n=6) of 2 x 106/mL sperm concentration are incubated with various
concentrations (0.5 nM, 5 µM, 50 µM, 0.5 mM and 1 mM) of DAF-2DA for 90 min at 37
ºC in dark. After incubation, the fluorescence of DAF-2T was measured using flow
cytometry along with control samples.

Measurement of sperm viability
Sperm viability was measured by the Eosin-Nigrosin staining procedure (see page
25, chapter II)

NO measurement in sperm after NOS inhibition
Sperm samples (n=8) at 2 x 106/mL concentration are incubated at 37ºC with
various concentrations (100, 400 and 800 µM) of the NOS inhibitor Nw –nitro -L-arginine

118

methyl ester (L-NAME) for 120 min in the dark. 15 min after the addition of L-NAME,
DAF-2DA is added to the samples to a final concentration of 20 µM. The fluorescence of
DAF-2T is measured immediately after incubation using flow cytometry. Samples
without incubation with L-NAME are taken as controls for this series of experiments.

NO measurement in the presence of an exogenous NO donor.
Sperm samples (n=6) at 2 x 106/mL concentration were incubated at 37ºC with
various concentrations (10, 100, 300, 500 and 800 µM) of the NO donor 2-(N,Ndiethylamino)-diazenolate-2-oxide, sodium salt (DEA-NONOate) for 45 min in dark.
DAF-2DA at 20 µM is added to the samples 45 min prior to the addition of the NO
donor. The fluorescence of DAF-2T was measured immediately after incubation using
flow cytometry. Samples in absence of NONOate are taken as controls.

Flow cytometry
Flow cytometry data acquisition is completed within 10-15 min from sample
preparation. The flow cytometer (FACScan; Becton Dickinson, San Jose, CA) is
equipped with a 515-nm argon laser as a light source. Samples are adjusted to have
20,000 cells examined for each assay at a flow rate of 100 cells/second. Data analysis is
performed using FlowJo v4.4.4 software (Tree Star Inc., Ashland, OR).
In our flow cytometry data, we used 20,000 count from the 2 x 106/mL total
sperm in each sample to obtain consistent measurements. The threshold value of the
forward scatter (FSC) was set < 40 FSC to exclude small cells, cell fragments, and debris
from the analyzed sperm. The sperm window was established after running multiple
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unstained sperm samples (instrumental control) submitted to swim up and followed by
washing with HTF.

Statistical analysis
All values were recorded as mean ± S.D. Differences between samples and their
control were considered significant at P < 0.05. Statistical analyses were performed by
one-way analysis of variance (ANOVA) and an unpaired Student’s t-test using the
SPSS/PC computer software (SPSS 10.0.7, SPSS Inc.)
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5.3 Results and discussion
The work we presented here is a modification of what Strijdom et al. (2004) and
S. du Plessis et al. (2006) have described [26; 27]. The fluorescent NO-indicators
diaminofluoresceins (DAFs) were first designed and synthesized by Kojima et al (1998)
[25]. DAF-2DA, a non-fluorescent dye, is able to cross the membrane of live cells and is
hydrolyzed to 4,5-diaminofluorescein (DAF-2) by intracellular esterases [28]. DAF-2
reacts rapidly with NO (in the presence of O2; the reaction is actually with an NO+
equivalent likely from a nitrogen oxide derivative of NO) to form the fluorescent dye
triazolofluorescein (DAF-2T) (Figure 5-1). DAF-2T fluoresces at 515 nm upon excitation
at 495 nm. Because of the specificity of the reaction of DAF-2 with NO, the intensity of
the fluorescence is proportional to the amount of intracellular NO generated.
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Figure 5-1: Schematic representation of fluorometric NO measurement procedure for
human spermatozoa using the DAF-2DA precursor.
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Effect of sperm concentrations on DAF-2T fluorescence at 20 µM DAF-2DA
To determine the optimum sperm concentration of samples used in our flow
cytometry measurements, we monitored DAF-2T fluorescence as a function sperm
concentration for a set concentration of the dye DAF-2DA at 20 µM (Figure 5-2). No
significant difference (P > 0.05; t-test) in average fluorescence is seen between sample
with sperm concentrations 0.5, 1.0 and 2.0 x 106/mL. On the other hand, a significant
difference (P < 0.05; t-test) in average fluorescence is observed at higher concentrations
(4 and 8 x 106/mL). Unstained control samples (i.e. 0.0 µM DAF-2DA) exhibit very
negligible fluorescence.
Our experiments indicate that concentrations in the range of 0.5-2.0 x 106/mL
could all be used for a set DAF-2DA concentration of 20 µM. Sample with higher sperm
concentrations such as 4x or 8x106/mL showed lower fluorescence, likely a direct result
of a lower ratio of DAF-2DA molecules per sperm cell.
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Figure 5-2: Observed fluorescence as a function of sperm concentration with 20
µM dye concentration. The values reported are averages ± standard deviations; n=6. The
control is the unstained sample.

124

Effect of DAF-2DA concentrations on observed fluorescence

Figure 5-3 shows flow cytometry histograms of DAF-2DT fluorescence (A) as
well as the mean areas for these histograms (B) at various concentrations of DAF-2DA
(0.5 nM -1 mM). All DAF-2DA concentrations used show a statistical increase (P < 0.05;
t-test) in fluorescence compared to unstained control samples (without DAF-2DA).
Sperm samples incubated with 50 µM of DAF-2DA show the highest intensity of DAF2T fluorescence, while the lowest fluorescence is seen for 0.5 nM dye concentration. The
intensity of the fluorescence decreased at higher doses (above 0.5 mM) of DAF-2DA
used.
Our results showed a statistically significant increase in fluorescence even at a low
concentration of DAF-2DA of ~ 0.5 nM compared to the control sample (without DAF2DA). Because concentrations of 0.5 mM and 1 mM of DAF-2DA exhibited lower
fluorescence compared to 50 M, we examined if sperm viability is compromised at
these higher concentrations. Indeed, we find that the millimolar range of dye
concentration significantly affects sperm viability, which explains the observed decrease
in fluorescence (Figure 5-4).
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Figure 5-3: (A) Flow cytometry histograms of DAF-2T fluorescence as a function of
concentrations of the DAF-2DA dye (0.5nM, 5µM, 50µM, 0.5mM, 1mM); (B) Mean
areas of DAF-2T fluorescence at the various DAF-2DA doses; data are means (for n=6) ±
standard deviations; the control is the unstained sample (i.e. no DAF-2DA). Sperm
concentration used in the sample was 2 x 106/mL with 20,000 cells acquired in flow
cytometry.
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Figure 5-4: Effect of various DAF-2DA concentrations on sperm viability as evaluated
by the Eosin-Nigrosin test. The evaluation of sperm viability performed immediately
after the flow cytometry measurements. Data are means (n=6) ± standard deviations.
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Dynamic NO sensitivity of DAF-2DA in the presence of NOS inhibitor and an NO donor.
To determine the dynamic sensitivity of this fluorometric method to sudden
variations of intracellular NO concentration in spermatozoa, we monitored fluorescence
changes in response to an NO donor as well as in the presence of a NOS-inhibitor.
a. Effect of the NOS inhibitor L-NAME on observed fluorescence
Figure 5-5 shows the effect of various concentrations (100, 400, and 800 µM) of
L-NAME on the observed DAF-2T fluorescence. Data represented are mean areas of
fluorescence ± standard deviations. The figure shows a significant decrease (P < 0.05) in
the intensity of fluorescence of DAF-2T in the presence of L-NAME in a dose dependent
manner. The fluorescence decrease of DAF-2T did not significantly change for L-NAME
concentrations between 100 and 400 µM (P > 0.05; t-test).
b. DAF-2T fluorescence in response to varying concentration of the NO donor
The specificity of DAF-2DA to measure NO and to respond to increases of
intracellular NO concentration was validated using incubation with DEA-NONOate, a
known NO donor.
Figure 5-6 shows the effect of various concentrations of DEA-NONOate, the NO
releasing compound, on observed fluorescence in human sperm. We observed significant
increase in fluorescence in samples with 100 µM NO donor concentration while the
change was not significant with 10 µM. Also, the mean area of DAF-2T fluorescence did
not increase significantly above the level measured with 100 µM NONOate for
concentrations above 300 µM.
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Figure 5-5: DAF-2T flow cytometry fluorescence in human sperm as a function of LNAME concentration. Data are means (n=10) ± standard deviation.
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Figure 5-6: DAF-2T flow cytometry fluorescence in human sperm as a function of
NONOate concentration. Data are means (n=6) ± standard deviations.
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Our results show that the fluorescence of DAF-2T increases after adding the NO
donor, indicating that the method follows dynamic increases of intracellular NO.
However, the method shows that the fluorescence did not increase significantly beyond
the level seen for 100 M of the NO donor. It is known that concentrations of NONOates
(in the range of 0.3- 1.0 mM) affect sperm motility [17]. In addition to sperm motility, we
suspected that sperm viability might be behind the sluggish increase (for 300 M) and
then decrease of DAF-2 fluorescence (for 500-800 M). To confirm this, we measured
the viability of sperm immediately after the flow cytometry analysis (Figure 5-7). As
expected, the figure shows a significant decrease in sperm viability after 100 µM in NO
donor. This is not a surprise since literature reports established that NO donors can have
both a protective role (at low concentration) but can also induce cell death in a variety of
cell types at high concentrations [29; 30]. The cytotoxic effects of NO are mainly due to
higher oxides that derive from NO and that are more reactive. Peroxynitrite is one of
them and has many reactivity facets under physiologic conditions which contribute to cell
dysfunction, including the disruption of the cell’s ability to sustain healthy levels of
endogenous NO, as well as other vital functions.
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Figure 5-7: Effect of varying concentration of NONOate on sperm viability as evaluated
by the Eosin-Nigrosin test. The viability test is conducted immediately after the flow
cytometry analysis. Sperm concentration was 2 x 106/mL. Data are means (n=6) ±
standard deviations.
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5.4 Conclusion
Collectively, these findings show that measurement of intracellular nitric oxide in
human sperm can be performed using the DAF-2DA fluorometric method coupled to
flow cytometry. The method has now been standardized for human spermatozoa and will
be of assistance to elucidate the NO mechanisms of action in human sperm as well as its
role in maintaining sperm quality or in inducing cytotoxicity.

5.5 Effect of L-Carnitine (LC) on NO production in human spermatozoa assessed by
the DAF-2DA fluorometric method coupled with flow cytometry
In this section, we measured the effect of L-carnitine (LC) on NO production in
human sperm using the method that we have standardized as described in the previous
section of this chapter. As we have seen in chapter III, supplementation of sperm with LC
at 0.5 mg/mL increased sperm motility. On the other hand, as we described previously,
nitric oxide has been implicated for adequate sperm function including motility. Our goal
here is to test whether LC supplementation causes the levels of endogenous NO to
increase in sperm. This may be a mechanism by which LC stimulates sperm motility.

Methodology and experimental design

Highly motile sperm were prepared using direct swim up and adjusted to 2 x
106/mL concentration with HTF. After that, Semen Samples (n=4) were supplemented
with 0.1 mg/mL LC, followed by addition of DAF-2DA at 20µM concentration. Samples
were then incubated for 90 min at 37°C in the dark. After incubation, the fluorescence of
DAF-2T formed was measured immediately using flow cytometry as described in above.
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Results and discussion
In chapter 2, we have shown that 0.5 mg/mL LC concentration is beneficial to
sperm at 5 million/mL. Here we supplemented the sperm with LC at 0.1 mg/mL because
we treated lower sperm number (2 million/mL). Figure 6-7 shows the effect of 0.1
mg/mL LC on DAF-2T fluorescence in human spermatozoa. The figure shows an
increase in DAF-2T fluorescence, and thus an increase in the intracellular NO produced
in the sperm supplemented with LC. Control samples assayed without LC
supplementation do not show any significant increase in fluorescence. Data in the figure
are representative of four independent experiments. As reported in chapter 4, NOS in all
of its isoforms is present in human spermatozoa. NO has a major role in the physiology
and function of the spermatozoa [10; 31]. A number of studies showed that NO is very
important for adequate motility of human spermatozoa [12; 17; 32]. Our results from the
fluorometric determination of intracellular NO production in spermatozoa upon
incubation with LC show a causal relationship between LC supplementation and NO
production. Whether the LC-induced NO production is direct or via an indirect pathway
cannot be concluded and awaits further investigation. For now, the evidence shows that
LC induces intracellular NO production, and this may explain the enhanced motility of
spermatozoa incubated with L-Carnitine.
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Figure 5-8: Effect of LC on DAF-2T fluorescence in human spermatozoa. Sperm (2 x
106/mL) incubated 90 min with 20 µM DAF-2DA in the presence of 0.1 mg/mL LC (a),
and without LC (b). The control histogram is for sperm population without DAF-2DA,
and without LC. Data are representative of four independent experiments.
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